Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
Tigilanol tiglate is a novel small molecule approved as a veterinary pharmaceutical in Europe for intratumoural treatment of non-metastatic, non-resectable canine mast cell tumors. The drug has a “tumor agnostic” mode of action associated with induction of an acute inflammatory response at the treat...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020-09-01
|
| coleção: | Frontiers in Veterinary Science |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/article/10.3389/fvets.2020.00639/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|